Clinical trial
Methotrexate Infusion and Intrasilicone Injection During Diabetic Vitrectomy
NCT06038968
Study timeline
Study start (actual)2022-09-01Date precision: day
Registry last updated2024-02-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetic Retinopathyunresolved
Vitreomacular Tractionunresolved
Interventions
Methotrexate 25 MG/MLDRUG · verified · RxNorm: methotrexate 25 MG/ML
parsplana vitrectomyPROCEDURE
Sponsors & collaborators
Minia Universitylead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06038968 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.